HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hydroxynimesulide, the main metabolite of nimesulide, prevents hydroperoxide/hemoglobin-induced hemolysis of rat erythrocytes.

Abstract
The protective effect of hydroxynimesulide, the main metabolite of the nonsteroidal antiinflammatory drug nimesulide, on red blood cells (RBCs, 0.2%; 3.5 x 10(7) cell/ml) hemolysis induced by cumene hydroperoxide (CuOOH; 50 microM) was evaluated by turbidimetric and morphological analyses. Hydroxynimesulide inhibits the CuOOH-induced hemolysis in a dose dependent fashion: the protective effect, calculated after 150 min incubation (100% hemolysis in the controls), starts at 1 micron (% hemolysis 85.2 +/- 3.4%) and increases at the higher concentrations (63.5 +/- 3.9% at 5 microM; 43.5 +/- 6.3% at 10 microM; and, 14.5 +/- 4.3% at 20 microM). In addition, in the samples protected with 10 microM and 20 microM, there is a significant delay (30 and 60 min) in the onset of the hemolytic response. Inhibition of hemolysis is the result of protection of RBC membrane integrity, both on lipid (cis-Parinaric acid fluorescence quenching was delayed by 53 +/- 10 sec vs. the controls at 1 micron, by 115 +/- 15 sec at 5 microM, with a lag phase of 240 +/C- 18 sec at 10 microM) and protein constituents, as determined by SDS-PAGE electrophoresis. In hemolysis experiments, the efficacy of hydroxynimesulide is comparable to that of alpha-tocopherol and a cooperative interaction between hydroxynimesulide and alpha-tocopherol (both at 10 microM) has been observed. These results indicate that hydroxynimesulide protects RBC membranes by directly quenching reactive oxygen species generated by hemoglobin/peroxide interaction. Evidence for a direct radical scavenging intervention of the metabolite comes from HPLC studies, which demonstrate a time-dependent consumption of hydroxynimesulide, with the concomitant formation of two main reaction (addition/oxidation) products.
AuthorsR Maffei Facino, M Carini, G Aldini, M T Calloni
JournalDrugs under experimental and clinical research (Drugs Exp Clin Res) Vol. 23 Issue 5-6 Pg. 157-65 ( 1997) ISSN: 0378-6501 [Print] SWITZERLAND
PMID9515225 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzene Derivatives
  • Hemoglobins
  • Membrane Proteins
  • Reactive Oxygen Species
  • Sulfonamides
  • 4-nitro-2-(4'-hydroxyphenoxy)methanesulfonanilide
  • cumene hydroperoxide
  • nimesulide
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (metabolism, pharmacology)
  • Benzene Derivatives (antagonists & inhibitors, metabolism, toxicity)
  • Chromatography, High Pressure Liquid
  • Drug Interactions
  • Erythrocyte Membrane (drug effects, metabolism)
  • Erythrocytes (drug effects)
  • Hemoglobins (metabolism, toxicity)
  • Hemolysis (drug effects)
  • Male
  • Membrane Proteins (blood)
  • Oxidation-Reduction
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species (metabolism)
  • Sulfonamides (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: